Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Transcranial Magnetic Stimulation and Oral Ketamine Combination Treatment for Post-Traumatic Stress Disorder (TMS-OK PTSD)

To see complete record on, please visit this link

Id: ACTRN12621000342819

Organisation Name: Thompson Institute, University of the Sunshine Coast

Overal Status: Not yet recruiting

Start Date: 29/04/2021

Brief Summary: This double-blinded, randomised controlled trial aims to determine the feasibility, tolerability, and safety of intermittent theta burst stimulation (iTBS) and oral ketamine (OK) as a combination treatment for PTSD. Given the complexity and broad range of symptom presentations in patients diagnosed with PTSD, this study seeks to capture changes in sleep quality, perceived stress, suicidality, depression, anhedonia, chronic pain, and social/occupational functioning. Findings from this study will help to identify the brain circuitry involved with and neural processes associated with these glutamatergic and GABAergic-based interventions.

  • Australia

Total execution time in seconds: 0.31660199165344